nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CES1—Mycophenolate mofetil—systemic scleroderma	0.406	0.568	CbGbCtD
Rufinamide—ALB—Captopril—systemic scleroderma	0.097	0.136	CbGbCtD
Rufinamide—ALB—Mycophenolate mofetil—systemic scleroderma	0.0764	0.107	CbGbCtD
Rufinamide—ALB—Prednisone—systemic scleroderma	0.0611	0.0855	CbGbCtD
Rufinamide—ALB—Methotrexate—systemic scleroderma	0.0306	0.0429	CbGbCtD
Rufinamide—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0239	0.0335	CbGbCtD
Rufinamide—CYP3A4—Prednisone—systemic scleroderma	0.0191	0.0268	CbGbCtD
Rufinamide—Increased appetite—Prednisone—systemic scleroderma	0.000682	0.00238	CcSEcCtD
Rufinamide—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00068	0.00238	CcSEcCtD
Rufinamide—Vertigo—Leflunomide—systemic scleroderma	0.000679	0.00237	CcSEcCtD
Rufinamide—Insomnia—Captopril—systemic scleroderma	0.000677	0.00237	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000677	0.00237	CcSEcCtD
Rufinamide—Leukopenia—Leflunomide—systemic scleroderma	0.000677	0.00237	CcSEcCtD
Rufinamide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000676	0.00236	CcSEcCtD
Rufinamide—Tremor—Mycophenolic acid—systemic scleroderma	0.000676	0.00236	CcSEcCtD
Rufinamide—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000673	0.00235	CcSEcCtD
Rufinamide—Urine output increased—Methotrexate—systemic scleroderma	0.000667	0.00233	CcSEcCtD
Rufinamide—Anaemia—Mycophenolic acid—systemic scleroderma	0.000667	0.00233	CcSEcCtD
Rufinamide—Somnolence—Captopril—systemic scleroderma	0.000666	0.00233	CcSEcCtD
Rufinamide—Agitation—Mycophenolic acid—systemic scleroderma	0.000663	0.00232	CcSEcCtD
Rufinamide—Dyspepsia—Captopril—systemic scleroderma	0.000659	0.0023	CcSEcCtD
Rufinamide—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.000656	0.00229	CcSEcCtD
Rufinamide—Mental disorder—Lisinopril—systemic scleroderma	0.000654	0.00229	CcSEcCtD
Rufinamide—Dizziness—Pentoxifylline—systemic scleroderma	0.000653	0.00228	CcSEcCtD
Rufinamide—Decreased appetite—Captopril—systemic scleroderma	0.000651	0.00227	CcSEcCtD
Rufinamide—Malnutrition—Lisinopril—systemic scleroderma	0.00065	0.00227	CcSEcCtD
Rufinamide—Infection—Azathioprine—systemic scleroderma	0.000649	0.00227	CcSEcCtD
Rufinamide—Vertigo—Mycophenolic acid—systemic scleroderma	0.000648	0.00226	CcSEcCtD
Rufinamide—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000646	0.00226	CcSEcCtD
Rufinamide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000646	0.00226	CcSEcCtD
Rufinamide—Fatigue—Captopril—systemic scleroderma	0.000645	0.00226	CcSEcCtD
Rufinamide—Anxiety—Leflunomide—systemic scleroderma	0.000641	0.00224	CcSEcCtD
Rufinamide—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000641	0.00224	CcSEcCtD
Rufinamide—Constipation—Captopril—systemic scleroderma	0.00064	0.00224	CcSEcCtD
Rufinamide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00064	0.00224	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000639	0.00223	CcSEcCtD
Rufinamide—Skin disorder—Azathioprine—systemic scleroderma	0.000635	0.00222	CcSEcCtD
Rufinamide—Back pain—Lisinopril—systemic scleroderma	0.000628	0.0022	CcSEcCtD
Rufinamide—Vomiting—Pentoxifylline—systemic scleroderma	0.000628	0.0022	CcSEcCtD
Rufinamide—Lymphadenopathy—Methotrexate—systemic scleroderma	0.000628	0.00219	CcSEcCtD
Rufinamide—Convulsion—Mycophenolic acid—systemic scleroderma	0.000625	0.00218	CcSEcCtD
Rufinamide—Rash—Pentoxifylline—systemic scleroderma	0.000623	0.00218	CcSEcCtD
Rufinamide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000622	0.00218	CcSEcCtD
Rufinamide—Headache—Pentoxifylline—systemic scleroderma	0.000619	0.00216	CcSEcCtD
Rufinamide—Infection—Leflunomide—systemic scleroderma	0.000613	0.00214	CcSEcCtD
Rufinamide—Vision blurred—Lisinopril—systemic scleroderma	0.000612	0.00214	CcSEcCtD
Rufinamide—Anxiety—Mycophenolic acid—systemic scleroderma	0.000612	0.00214	CcSEcCtD
Rufinamide—Asthenia—Mometasone—systemic scleroderma	0.000612	0.00214	CcSEcCtD
Rufinamide—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00214	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00061	0.00213	CcSEcCtD
Rufinamide—Polyuria—Methotrexate—systemic scleroderma	0.00061	0.00213	CcSEcCtD
Rufinamide—Tremor—Lisinopril—systemic scleroderma	0.000609	0.00213	CcSEcCtD
Rufinamide—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00212	CcSEcCtD
Rufinamide—Nervous system disorder—Leflunomide—systemic scleroderma	0.000605	0.00212	CcSEcCtD
Rufinamide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000604	0.00211	CcSEcCtD
Rufinamide—Pruritus—Mometasone—systemic scleroderma	0.000603	0.00211	CcSEcCtD
Rufinamide—Anaemia—Lisinopril—systemic scleroderma	0.0006	0.0021	CcSEcCtD
Rufinamide—Skin disorder—Leflunomide—systemic scleroderma	0.000599	0.00209	CcSEcCtD
Rufinamide—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000589	0.00206	CcSEcCtD
Rufinamide—Anorexia—Leflunomide—systemic scleroderma	0.000588	0.00206	CcSEcCtD
Rufinamide—Nausea—Pentoxifylline—systemic scleroderma	0.000587	0.00205	CcSEcCtD
Rufinamide—Infection—Mycophenolic acid—systemic scleroderma	0.000585	0.00204	CcSEcCtD
Rufinamide—Vertigo—Lisinopril—systemic scleroderma	0.000584	0.00204	CcSEcCtD
Rufinamide—Diarrhoea—Mometasone—systemic scleroderma	0.000583	0.00204	CcSEcCtD
Rufinamide—Leukopenia—Lisinopril—systemic scleroderma	0.000582	0.00203	CcSEcCtD
Rufinamide—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000577	0.00202	CcSEcCtD
Rufinamide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000576	0.00201	CcSEcCtD
Rufinamide—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000573	0.002	CcSEcCtD
Rufinamide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000572	0.002	CcSEcCtD
Rufinamide—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00199	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000564	0.00197	CcSEcCtD
Rufinamide—Anorexia—Mycophenolic acid—systemic scleroderma	0.000561	0.00196	CcSEcCtD
Rufinamide—Insomnia—Leflunomide—systemic scleroderma	0.000558	0.00195	CcSEcCtD
Rufinamide—Anxiety—Lisinopril—systemic scleroderma	0.000551	0.00193	CcSEcCtD
Rufinamide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00192	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000549	0.00192	CcSEcCtD
Rufinamide—Dyspepsia—Leflunomide—systemic scleroderma	0.000543	0.0019	CcSEcCtD
Rufinamide—Vomiting—Mometasone—systemic scleroderma	0.000542	0.00189	CcSEcCtD
Rufinamide—Rash—Mometasone—systemic scleroderma	0.000537	0.00188	CcSEcCtD
Rufinamide—Asthenia—Captopril—systemic scleroderma	0.000537	0.00188	CcSEcCtD
Rufinamide—Dermatitis—Mometasone—systemic scleroderma	0.000537	0.00188	CcSEcCtD
Rufinamide—Decreased appetite—Leflunomide—systemic scleroderma	0.000536	0.00187	CcSEcCtD
Rufinamide—Headache—Mometasone—systemic scleroderma	0.000534	0.00187	CcSEcCtD
Rufinamide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000533	0.00186	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000533	0.00186	CcSEcCtD
Rufinamide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000532	0.00186	CcSEcCtD
Rufinamide—Fatigue—Leflunomide—systemic scleroderma	0.000532	0.00186	CcSEcCtD
Rufinamide—Pruritus—Captopril—systemic scleroderma	0.00053	0.00185	CcSEcCtD
Rufinamide—Constipation—Leflunomide—systemic scleroderma	0.000528	0.00184	CcSEcCtD
Rufinamide—Infection—Lisinopril—systemic scleroderma	0.000527	0.00184	CcSEcCtD
Rufinamide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000526	0.00184	CcSEcCtD
Rufinamide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000523	0.00183	CcSEcCtD
Rufinamide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000523	0.00183	CcSEcCtD
Rufinamide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000519	0.00181	CcSEcCtD
Rufinamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000518	0.00181	CcSEcCtD
Rufinamide—Neutropenia—Prednisone—systemic scleroderma	0.000518	0.00181	CcSEcCtD
Rufinamide—Skin disorder—Lisinopril—systemic scleroderma	0.000515	0.0018	CcSEcCtD
Rufinamide—Diarrhoea—Captopril—systemic scleroderma	0.000512	0.00179	CcSEcCtD
Rufinamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000512	0.00179	CcSEcCtD
Rufinamide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00179	CcSEcCtD
Rufinamide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00178	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000508	0.00178	CcSEcCtD
Rufinamide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000508	0.00177	CcSEcCtD
Rufinamide—Nausea—Mometasone—systemic scleroderma	0.000506	0.00177	CcSEcCtD
Rufinamide—Anorexia—Lisinopril—systemic scleroderma	0.000505	0.00177	CcSEcCtD
Rufinamide—Ataxia—Methotrexate—systemic scleroderma	0.000503	0.00176	CcSEcCtD
Rufinamide—Constipation—Mycophenolic acid—systemic scleroderma	0.000503	0.00176	CcSEcCtD
Rufinamide—Weight decreased—Prednisone—systemic scleroderma	0.000501	0.00175	CcSEcCtD
Rufinamide—Dizziness—Captopril—systemic scleroderma	0.000495	0.00173	CcSEcCtD
Rufinamide—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00172	CcSEcCtD
Rufinamide—Breast disorder—Methotrexate—systemic scleroderma	0.000484	0.00169	CcSEcCtD
Rufinamide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00169	CcSEcCtD
Rufinamide—Hypersensitivity—Azathioprine—systemic scleroderma	0.000481	0.00168	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00168	CcSEcCtD
Rufinamide—Insomnia—Lisinopril—systemic scleroderma	0.00048	0.00168	CcSEcCtD
Rufinamide—Vomiting—Captopril—systemic scleroderma	0.000476	0.00166	CcSEcCtD
Rufinamide—Rash—Captopril—systemic scleroderma	0.000472	0.00165	CcSEcCtD
Rufinamide—Dermatitis—Captopril—systemic scleroderma	0.000472	0.00165	CcSEcCtD
Rufinamide—Somnolence—Lisinopril—systemic scleroderma	0.000471	0.00165	CcSEcCtD
Rufinamide—Headache—Captopril—systemic scleroderma	0.000469	0.00164	CcSEcCtD
Rufinamide—Dyspepsia—Lisinopril—systemic scleroderma	0.000467	0.00163	CcSEcCtD
Rufinamide—Infection—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00161	CcSEcCtD
Rufinamide—Decreased appetite—Lisinopril—systemic scleroderma	0.000461	0.00161	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000458	0.0016	CcSEcCtD
Rufinamide—Fatigue—Lisinopril—systemic scleroderma	0.000457	0.0016	CcSEcCtD
Rufinamide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00159	CcSEcCtD
Rufinamide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00159	CcSEcCtD
Rufinamide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000455	0.00159	CcSEcCtD
Rufinamide—Constipation—Lisinopril—systemic scleroderma	0.000453	0.00158	CcSEcCtD
Rufinamide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00158	CcSEcCtD
Rufinamide—Diarrhoea—Azathioprine—systemic scleroderma	0.000447	0.00156	CcSEcCtD
Rufinamide—Nausea—Captopril—systemic scleroderma	0.000445	0.00155	CcSEcCtD
Rufinamide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00155	CcSEcCtD
Rufinamide—Asthenia—Leflunomide—systemic scleroderma	0.000443	0.00155	CcSEcCtD
Rufinamide—Pruritus—Leflunomide—systemic scleroderma	0.000437	0.00153	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—systemic scleroderma	0.000433	0.00151	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—systemic scleroderma	0.000433	0.00151	CcSEcCtD
Rufinamide—Dizziness—Azathioprine—systemic scleroderma	0.000432	0.00151	CcSEcCtD
Rufinamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000422	0.00148	CcSEcCtD
Rufinamide—Diarrhoea—Leflunomide—systemic scleroderma	0.000422	0.00148	CcSEcCtD
Rufinamide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00147	CcSEcCtD
Rufinamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000416	0.00146	CcSEcCtD
Rufinamide—Vomiting—Azathioprine—systemic scleroderma	0.000415	0.00145	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—systemic scleroderma	0.000415	0.00145	CcSEcCtD
Rufinamide—Eye disorder—Prednisone—systemic scleroderma	0.000414	0.00145	CcSEcCtD
Rufinamide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000413	0.00144	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—systemic scleroderma	0.000413	0.00144	CcSEcCtD
Rufinamide—Infestation—Methotrexate—systemic scleroderma	0.000413	0.00144	CcSEcCtD
Rufinamide—Rash—Azathioprine—systemic scleroderma	0.000412	0.00144	CcSEcCtD
Rufinamide—Dermatitis—Azathioprine—systemic scleroderma	0.000412	0.00144	CcSEcCtD
Rufinamide—Headache—Azathioprine—systemic scleroderma	0.000409	0.00143	CcSEcCtD
Rufinamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00143	CcSEcCtD
Rufinamide—Dizziness—Leflunomide—systemic scleroderma	0.000408	0.00143	CcSEcCtD
Rufinamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00141	CcSEcCtD
Rufinamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000403	0.00141	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000401	0.0014	CcSEcCtD
Rufinamide—Immune system disorder—Prednisone—systemic scleroderma	0.0004	0.0014	CcSEcCtD
Rufinamide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00139	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—systemic scleroderma	0.000393	0.00138	CcSEcCtD
Rufinamide—Vomiting—Leflunomide—systemic scleroderma	0.000392	0.00137	CcSEcCtD
Rufinamide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000391	0.00137	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00039	0.00136	CcSEcCtD
Rufinamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000389	0.00136	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—systemic scleroderma	0.000389	0.00136	CcSEcCtD
Rufinamide—Rash—Leflunomide—systemic scleroderma	0.000389	0.00136	CcSEcCtD
Rufinamide—Dermatitis—Leflunomide—systemic scleroderma	0.000389	0.00136	CcSEcCtD
Rufinamide—Mental disorder—Prednisone—systemic scleroderma	0.000388	0.00136	CcSEcCtD
Rufinamide—Nausea—Azathioprine—systemic scleroderma	0.000388	0.00136	CcSEcCtD
Rufinamide—Headache—Leflunomide—systemic scleroderma	0.000387	0.00135	CcSEcCtD
Rufinamide—Malnutrition—Prednisone—systemic scleroderma	0.000386	0.00135	CcSEcCtD
Rufinamide—Asthenia—Lisinopril—systemic scleroderma	0.00038	0.00133	CcSEcCtD
Rufinamide—Pruritus—Lisinopril—systemic scleroderma	0.000375	0.00131	CcSEcCtD
Rufinamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000374	0.00131	CcSEcCtD
Rufinamide—Rash—Mycophenolic acid—systemic scleroderma	0.000371	0.0013	CcSEcCtD
Rufinamide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000371	0.0013	CcSEcCtD
Rufinamide—Headache—Mycophenolic acid—systemic scleroderma	0.000369	0.00129	CcSEcCtD
Rufinamide—Nausea—Leflunomide—systemic scleroderma	0.000367	0.00128	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000366	0.00128	CcSEcCtD
Rufinamide—Vision blurred—Prednisone—systemic scleroderma	0.000364	0.00127	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—systemic scleroderma	0.000363	0.00127	CcSEcCtD
Rufinamide—Diarrhoea—Lisinopril—systemic scleroderma	0.000363	0.00127	CcSEcCtD
Rufinamide—Anaemia—Prednisone—systemic scleroderma	0.000357	0.00125	CcSEcCtD
Rufinamide—Agitation—Prednisone—systemic scleroderma	0.000355	0.00124	CcSEcCtD
Rufinamide—Dizziness—Lisinopril—systemic scleroderma	0.000351	0.00123	CcSEcCtD
Rufinamide—Nausea—Mycophenolic acid—systemic scleroderma	0.00035	0.00122	CcSEcCtD
Rufinamide—Vertigo—Prednisone—systemic scleroderma	0.000347	0.00121	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—systemic scleroderma	0.000346	0.00121	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—systemic scleroderma	0.000344	0.0012	CcSEcCtD
Rufinamide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000342	0.0012	CcSEcCtD
Rufinamide—Vomiting—Lisinopril—systemic scleroderma	0.000337	0.00118	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—systemic scleroderma	0.000335	0.00117	CcSEcCtD
Rufinamide—Rash—Lisinopril—systemic scleroderma	0.000334	0.00117	CcSEcCtD
Rufinamide—Convulsion—Prednisone—systemic scleroderma	0.000334	0.00117	CcSEcCtD
Rufinamide—Dermatitis—Lisinopril—systemic scleroderma	0.000334	0.00117	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000334	0.00117	CcSEcCtD
Rufinamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00116	CcSEcCtD
Rufinamide—Headache—Lisinopril—systemic scleroderma	0.000332	0.00116	CcSEcCtD
Rufinamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000329	0.00115	CcSEcCtD
Rufinamide—Anxiety—Prednisone—systemic scleroderma	0.000327	0.00114	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000326	0.00114	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—systemic scleroderma	0.000325	0.00113	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—systemic scleroderma	0.000322	0.00113	CcSEcCtD
Rufinamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00111	CcSEcCtD
Rufinamide—Nausea—Lisinopril—systemic scleroderma	0.000315	0.0011	CcSEcCtD
Rufinamide—Infection—Prednisone—systemic scleroderma	0.000313	0.00109	CcSEcCtD
Rufinamide—Back pain—Methotrexate—systemic scleroderma	0.000312	0.00109	CcSEcCtD
Rufinamide—Nervous system disorder—Prednisone—systemic scleroderma	0.000309	0.00108	CcSEcCtD
Rufinamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00107	CcSEcCtD
Rufinamide—Skin disorder—Prednisone—systemic scleroderma	0.000306	0.00107	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—systemic scleroderma	0.000304	0.00106	CcSEcCtD
Rufinamide—Anorexia—Prednisone—systemic scleroderma	0.0003	0.00105	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—systemic scleroderma	0.000298	0.00104	CcSEcCtD
Rufinamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00103	CcSEcCtD
Rufinamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00102	CcSEcCtD
Rufinamide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00102	CcSEcCtD
Rufinamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00102	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—systemic scleroderma	0.00029	0.00101	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—systemic scleroderma	0.000289	0.00101	CcSEcCtD
Rufinamide—Insomnia—Prednisone—systemic scleroderma	0.000285	0.000995	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—systemic scleroderma	0.000279	0.000976	CcSEcCtD
Rufinamide—Dyspepsia—Prednisone—systemic scleroderma	0.000277	0.000969	CcSEcCtD
Rufinamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000964	CcSEcCtD
Rufinamide—Decreased appetite—Prednisone—systemic scleroderma	0.000274	0.000957	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000273	0.000953	CcSEcCtD
Rufinamide—Fatigue—Prednisone—systemic scleroderma	0.000271	0.000949	CcSEcCtD
Rufinamide—Constipation—Prednisone—systemic scleroderma	0.000269	0.000941	CcSEcCtD
Rufinamide—Infection—Methotrexate—systemic scleroderma	0.000261	0.000914	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—systemic scleroderma	0.000258	0.000902	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000258	0.000901	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—systemic scleroderma	0.000256	0.000893	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—systemic scleroderma	0.000251	0.000877	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—systemic scleroderma	0.000238	0.000832	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—systemic scleroderma	0.000234	0.000818	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisone—systemic scleroderma	0.000232	0.000811	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—systemic scleroderma	0.000232	0.00081	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—systemic scleroderma	0.000229	0.0008	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000227	0.000794	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—systemic scleroderma	0.000227	0.000793	CcSEcCtD
Rufinamide—Asthenia—Prednisone—systemic scleroderma	0.000226	0.00079	CcSEcCtD
Rufinamide—Pruritus—Prednisone—systemic scleroderma	0.000223	0.000779	CcSEcCtD
Rufinamide—Diarrhoea—Prednisone—systemic scleroderma	0.000215	0.000753	CcSEcCtD
Rufinamide—Dizziness—Prednisone—systemic scleroderma	0.000208	0.000728	CcSEcCtD
Rufinamide—Vomiting—Prednisone—systemic scleroderma	0.0002	0.0007	CcSEcCtD
Rufinamide—Rash—Prednisone—systemic scleroderma	0.000199	0.000694	CcSEcCtD
Rufinamide—Dermatitis—Prednisone—systemic scleroderma	0.000198	0.000693	CcSEcCtD
Rufinamide—Headache—Prednisone—systemic scleroderma	0.000197	0.000689	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000194	0.000678	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—systemic scleroderma	0.000189	0.00066	CcSEcCtD
Rufinamide—Nausea—Prednisone—systemic scleroderma	0.000187	0.000654	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—systemic scleroderma	0.000186	0.000651	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—systemic scleroderma	0.00018	0.000629	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—systemic scleroderma	0.000174	0.000608	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—systemic scleroderma	0.000167	0.000585	CcSEcCtD
Rufinamide—Rash—Methotrexate—systemic scleroderma	0.000166	0.00058	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—systemic scleroderma	0.000166	0.000579	CcSEcCtD
Rufinamide—Headache—Methotrexate—systemic scleroderma	0.000165	0.000576	CcSEcCtD
Rufinamide—Nausea—Methotrexate—systemic scleroderma	0.000156	0.000546	CcSEcCtD
